Skip to content

Clinical trials

Thrombocytopenia trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Country / region: Czechia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20063
20101
20111
20121
20132
20142
20161
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated3
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Novartis Pharmaceuticals3
CTI BioPharma2
Bristol-Myers Squibb1
Eisai Inc.1
Insel Gruppe AG, University Hospital Bern1
Karyopharm Therapeutics Inc1
UCB Biopharma SRL1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia14
Anemia3
Myelodysplastic Syndromes3
Myeloproliferative Disorders3
Primary Myelofibrosis3
Purpura, Thrombocytopenic, Idiopathic3
Bone Marrow Diseases2
Hematologic Diseases2
Polycythemia Vera2
Purpura2

Trials

Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.